ÇѸ²´ëÇб³¼º½Éº´¿ø

Àå´ë¿µ ±³¼ö

031-380-3704 fhdzang@hallym.or.kr
  • Áø·á°ú Ç÷¾×Á¾¾ç³»°ú

Àü¹®Áø·áºÐ¾ß

¼ÒÈ­±â¾Ï(À§¾Ï, ´ëÀå¾Ï, °£´ãµµÃéÀå¾Ï µî), Ç÷¾×Áúȯ(¹éÇ÷º´, °ñ¼öÀÌÇü¼ºÁõ µî)

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2022-08-15 ~ 2022-08-20)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¿Ü·¡Áø·á¿Ü·¡Áø·á¿Ü·¡Áø·á
¿ÀÈÄ ¿Ü·¡Áø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

ÇѸ²´ëÇб³ Àǰú´ëÇÐ ÀÇÇйڻç(MD, Ph.D)

Fred Hutchinson Cancer Research Center (FHCRC), Seattle, USA, Post-Doc

°æ·Â

°æ·Â

Çö) ´ëÇÑÇ׾Ͽä¹ý¿¬±¸È¸(KCSG) ȸÀå, ÀÌ»çȸÀÇÀå

Çö) ÇѸ²´ëÇб³¼º½Éº´¿ø Ç÷¾×¡¤Á¾¾ç³»°ú ±³¼ö

Çö) ÇѸ²´ëÇб³ÀÇ·á¿ø Áß¾ÓÀÓ»óÀÇÇבּ¸¼Ò ¼ÒÀå

Weil Cornell Cancer Center, New York, USA, Visiting Professor

FHCRC, Research Associate, Seattle, USA

¼­¿ï¾Æ»êº´¿ø Á¾¾çÇ÷¾×³»°ú ÀÓ»ó°­»ç

ÇÐȸȰµ¿

ÇÐȸȰµ¿

±¹°¡Ç׾Ͻžళ¹ß»ç¾÷´Ü Çö)ÀÚ¹®À§¿ø

±¹¹Î°Ç°­º¸Çè°ø´Ü Çö)¾àÁ¦±Þ¿©Æò°¡À§¿ø, Çö)»êÁ¤Æ¯·ÊÀ§¿ø

°Ç°­º¸Çè½É»çÆò°¡¿ø Çö)¾ÏÁúȯ½ÉÀÇÀ§¿ø

½ÄǰÀǾàǰ¾ÈÀüó Çö)Ç×¾ÏÁ¦Àü·«ÀÚ¹®À§¿ø, Çö)Áß¾Ó¾à»ç½ÉÀÇÀ§¿ø, Çö)½É¼Ó½ÉÀÇÀÚ¹®À§¿ø

°ú±âºÎ »ý¸í°øÇבּ¸¿ø Çö)¹ÙÀÌ¿À±ÔÁ¦À§¿ø

´ëÇÑÀ§¾ÏÇÐȸ Çö)»óÀÓÀÌ»ç

´ëÇÑÁ¾¾ç³»°úÇÐȸ Çö)À±¸®À§¿øÀå, ±âȹÀÌ»ç

´ëÇѾÏÇÐȸ °Ç°­º¸ÇèÁ¤Ã¥À§¿øÀå

´ëÇÑÇ÷¾×ÇÐȸ ±³À°¼ö·ÃÀÌ»ç, »çȸºÀ»ç±³À°ÀÌ»ç

¼ö»óÀÌ·Â

¼ö»óÀÌ·Â

¹Ì±¹Ç÷¾×ÇÐȸ ¿ì¼ö³í¹®»ó

ÇѸ²´ëÇб³ Çмú»ó

³í¹®

Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16) (GASTRIC CANCER)

Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing (Journal of Oncology)

A phase II study of chemotherapy in combination with telomerase peptide vaccine (GV1001) as second-line treatment in patients with metastatic colorectal cancer (Journal of Cancer)

Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen (Journal of Cancer Research and Clinical Oncology)

Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group (Cancer Research and Treatment)

Clinical insights into hematologic malignancies and comparative analysis of molecular signatures of acute myeloid leukemia in different ethnicities using an artificial intelligence offering (Medicine (United States))

A Bayesian network meta-analysis on systemic therapy for previously treated gastric cancer (Critical Reviews in Oncology/Hematology)

Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3) (European Journal of Cancer)

Treatment and Outcomes of Metastatic Pancreatic Cancer in Elderly Patients (Chemotherapy)

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer (Journal of clinical oncology : official journal of the American Society of Clinical Oncology)
À§¾Ï ÀÓ»óÁø·áÁöħ (Çѱ¹ÀÓ»ó¾ÏÇÐȸ)

À§¾ÏÇ¥ÁØÁø·á±Ç°í¾È (´ëÇÑÀÇÇÐȸ)

ȯ¿ì¿Í °¡Á·À» À§ÇÑ Ç÷¾× Áúȯ ¼Ò°³¼­ (´ëÇÑÇ÷¾×ÇÐȸ)

Ç÷¾×ÇÐ / Hematology ((ÁÖ)¹ü¹®¿¡µàÄÉÀ̼Ç)

RECTAL CANCER-a multidisciplinary approach to management (Intech)

Ç÷¾×ÇÐ / hematology (E*public)